Patient-derived ovarian cancer organoids capture the genomic profiles of primary tumours applicable for drug sensitivity and resistance testing

The use of primary patient-derived organoids for drug sensitivity and resistance testing could play an important role in precision cancer medicine. We developed expandable ovarian cancer organoids in < 3 weeks; these organoids captured the characteristics of histological cancer subtypes and repli...

Descripción completa

Detalles Bibliográficos
Autores principales: Nanki, Yoshiko, Chiyoda, Tatsuyuki, Hirasawa, Akira, Ookubo, Aki, Itoh, Manabu, Ueno, Masaru, Akahane, Tomoko, Kameyama, Kaori, Yamagami, Wataru, Kataoka, Fumio, Aoki, Daisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387538/
https://www.ncbi.nlm.nih.gov/pubmed/32724113
http://dx.doi.org/10.1038/s41598-020-69488-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387538/
https://www.ncbi.nlm.nih.gov/pubmed/32724113
http://dx.doi.org/10.1038/s41598-020-69488-9

Ejemplares similares